107 studies found for:    Open Studies | "Carcinoma, Ductal, Breast"
Show Display Options
Rank Status Study
21 Recruiting Safety and Efficacy Study of the Xoft® Axxent® eBx™ IORT System
Conditions: Invasive Ductal Carcinoma;   Ductal Carcinoma in Situ
Intervention: Radiation: Intra-operative Radiation Therapy - IORT
22 Recruiting A Phase II Study of Neoadjuvant FOLFIRINOX
Condition: Resectable Pancreatic Ductal Adenocarcinoma
Intervention: Drug: FOLFIRINOX
23 Not yet recruiting Dose-Escalation Study Of Palbociclib + Nab-Paclitaxel In mPDAC
Condition: Metastatic Pancreatic Ductal Adenocarcinoma
Interventions: Drug: Palbociclib;   Drug: Nab-Paclitaxel
24 Recruiting Caloric Restriction in Treating Patients With Stage 0-I Breast Cancer Undergoing Surgery and Radiation Therapy
Conditions: Ductal Breast Carcinoma in Situ;   Invasive Ductal Breast Carcinoma;   Invasive Lobular Breast Carcinoma;   Lobular Breast Carcinoma in Situ;   Recurrent Breast Cancer;   Stage IA Breast Cancer;   Stage IB Breast Cancer
Interventions: Behavioral: Behavioral dietary intervention;   Procedure: Therapeutic conventional surgery;   Radiation: Radiation therapy;   Other: Counseling intervention;   Procedure: Quality-of-life assessment
25 Not yet recruiting A Phase II Study of siG12D LODER in Combination With Chemotherapy in Patients With Unresectable Locally Advanced Pancreatic Cancer
Conditions: Pancreatic Ductal Adenocarcinoma;   Pancreatic Cancer
Interventions: Drug: siG12D LODER;   Drug: Gemcitabine or FOLFIRINOX
26 Recruiting Naltrexone RCT for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast Cancer
Conditions: Invasive Breast Cancer (Stage I-III);   Ductal Carcinoma in Situ;   Lobular Carcinoma in Situ;   Lobular Carcinoma;   Fatigue Related to Cancer Treatment
Interventions: Drug: Naltrexone;   Drug: Sugar Pill
27 Recruiting Diagnostic Study of Early Breast Cancer Using Ultrasound
Condition: Ductal Carcinoma In-situ
Intervention: Drug: Perflutren lipid microsphere
28 Recruiting Contrast-Enhanced MRI in Women With Ductal Breast Carcinoma in Situ and in Healthy Volunteers
Condition: Breast Cancer
Intervention: Procedure: contrast-enhanced magnetic resonance imaging
29 Recruiting Study to Assess Perfusion and Patient Satisfaction in Nipple-Areola Mastectomy With Immediate Reconstruction
Conditions: Ductal Carcinoma in Situ - Category;   Breast Cancer;   Prophylactic Mastectomy
Interventions: Procedure: Inframammary Fold Incision or Lateral Radial Incision;   Procedure: Lateral Radial Incision;   Procedure: Inframammary Fold Incision;   Device: Laser-assisted fluorescence angiography
30 Recruiting Letrozole in Treating Postmenopausal Women With Ductal Carcinoma in Situ
Condition: Breast Cancer
Interventions: Drug: letrozole;   Procedure: MRI;   Procedure: conventional surgery
31 Recruiting Phase II Study of Preoperative FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel in Patients With Resectable Pancreatic Cancer
Conditions: Resectable Pancreatic Cancer;   Pancreatic Ductal Carcinoma
Interventions: Drug: FOLFIRINOX;   Drug: Gemcitabine/nab-Paclitaxel;   Radiation: Radiation therapy;   Drug: Capecitabine
32 Unknown  Sorafenib Combined With Chemotherapy for Renal Collecting Duct Carcinoma
Condition: Renal Cell Carcinoma
Interventions: Drug: Sorafenib;   Drug: Gemcitabine;   Drug: Cisplatin
33 Recruiting Phase I/II Study of IMMU-132 in Patients With Epithelial Cancers
Conditions: Colorectal Cancer;   Gastric Adenocarcinoma;   Esophageal Cancer;   Hepatocellular Carcinoma;   Non-small Cell Lung Cancer;   Small Cell Lung Cancer;   Ovarian Epithelial Cancer;   Carcinoma Breast Stage IV;   Hormone-refractory Prostate Cancer;   Pancreatic Ductal Adenocarcinoma;   Head and Neck Cancers- Squamous Cell;   Renal Cell Cancer;   Urinary Bladder Neoplasms;   Cervical Cancer;   Endometrial Cancer;   Follicular Thyroid Cancer;   Glioblastoma Multiforme
Intervention: Drug: IMMU-132
34 Recruiting Evaluation of the Diagnostic Performance of MRI±Biopsy to Optimize Resection of Ductal Carcinoma In Situ (DCIS) Breast Cancer
Condition: Breast Cancer
Intervention: Procedure: MRI±biopsy
35 Recruiting Intra-operative Radiotherapy For Women With Ductal Carcinoma in Situ Breast Cancer
Condition: Breast Neoplasms
Intervention: Device: Intraoperative Radiotherapy
36 Not yet recruiting Prognostic Value of the Marker P63 in Adenocarcinoma of Lung, Breast, and Pancreas
Conditions: Lung Adenocarcinoma;   Breast Adenocarcinoma;   Pancreatic Ductal Adenocarcinoma
Intervention: Other: their will be no intervention in any of the groups, the study is retrospective
37 Recruiting Study of Gemcitabine, Abraxane® Plus Placebo Versus Gemcitabine, Abraxane® Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With 1st-Line Metastatic Pancreatic Ductal Adenocarcinoma
Condition: Pancreatic Cancer
Interventions: Drug: Demcizumab;   Drug: Abraxane®;   Drug: gemcitabine;   Drug: Placebo
38 Not yet recruiting Study of Tremelimumab in Patients With Advanced Solid Tumors
Condition: UBC (Urothelial Bladder Cancer)/ TNBC (Triple-negative Breast Cancer)/ PDAC (Pancreatic Ductal Adenocarcinoma)
Interventions: Biological: Tremelimumab monotherapy;   Biological: MEDI4736 monotherapy;   Biological: MEDI4736 + tremelimumab combination therapy
39 Recruiting Nipple-Areola Complex (NAC) Irradiation After Nipple-Sparing Mastectomy and Reconstruction
Conditions: Breast Cancer;   Ductal Carcinoma
Interventions: Procedure: Nipple-Sparing Mastectomy;   Radiation: Prophylactic Nipple-Areolar Complex RT;   Procedure: Immediate Breast Reconstruction;   Procedure: Axillary surgery;   Drug: Chemotherapy
40 Recruiting Oncologic Impact of Splenectomy-omitting Radical Pancreatectomy in Well-selected Left-sided Pancreatic Cancer
Conditions: Left-sided Pancreatic Cancer;   Ductal Adenocarcinoma
Interventions: Procedure: Radical Antegrade Modular Pancreatectomy with Splenectomy;   Procedure: Radical Antegrade Modular Pancreatectomy without splenectomy

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years